Table 5.
In vivo protein binding in dogs
| Time after dosing [h] | In vivo protein binding (%) mean, ± SEM | ||
|---|---|---|---|
| Male, 20 mg/kg p.o. | Female, 20 mg/kg p.o. | Female, 1 mg/kg i.v. | |
| 2 | 60 (n < 3) | 69 (n < 3) | 59 ± 0.69 |
| 4 | 63 ± 1.62 | 66 ± 0.69 | 66 ± 2.66 |
| 8 | 67 ± 2.71 | 62 ± 7.68 | 72 ± 1.33 |
In vivo protein binding of [14C] imepitoin in three male and three female dogs after oral dosing of 20 mg/kg filled in gelatin capsules, 0.792 MBq/kg, and i.v. dosing of 1 mg/kg dissolved in 70% DMSO in saline, 0.792 MBq/kg, to three female dogs. Displayed is mean ± SEM of three dogs at different time points after dosing. For the 2-h time point after oral dosing, insufficient plasma was obtained for two of three dogs. Protein binding was determined by ultracentrifugation.